Syntax For Science: Optimapharm takes over Spanish Syntax for Science SL

Optimapharm d.o.o. (“Optimapharm” or “the Company”), a leading independent clinical research organization (CRO) in Europe, is delighted to announce the acquisition of Syntax for Science S.L. (“Syntax for Science”), significantly strengthening its presence in the key European markets of Spain and Portugal, and expanding its service profile to offer full service, in-house capabilities for our biopharmaceutical clients worldwide.